Munich Re has delivered a landmark financial performance for 2025, setting a new profit record and outlining a substantial capital return program for its investors. However, the market’s focus is shifting from these headline figures to emerging challenges in the reinsurance sector, where a key cycle of price increases appears to be reversing.
Record Profits and Enhanced Shareholder Rewards
The German reinsurance giant reported a net profit of €6.121 billion for 2025, slightly surpassing its own target of €6.0 billion. This marks the fifth consecutive year the group has exceeded its forecasts. The company’s return on equity reached 18.3%, supported by a robust solvency ratio of 298%.
In recognition of this performance, the board intends to propose a dividend of €24.00 per share for the 2025 financial year. This represents a 20% increase over the prior year and exceeds the market consensus expectation of €21.86. Furthermore, Munich Re announced a share buyback program of up to €2.25 billion, scheduled to run from 29 April 2026 until no later than the Annual General Meeting on 29 April 2027. The total planned capital return to shareholders thus amounts to €5.3 billion.
Despite these announcements, investor sentiment has been tempered recently. Over the past seven trading days, the share price declined by 4.78%, closing at €530.00 on Tuesday—a level virtually identical to its 50-day moving average.
A Strong Year with a Fourth-Quarter Slowdown
While the full-year results set a new benchmark, the final quarter presented some headwinds. Fourth-quarter net income came in at €945 million, approximately 12% lower than the same period a year earlier. This was primarily attributed to negative currency effects related to the US dollar.
Growth in the life and health reinsurance segment, alongside contributions from the ERGO primary insurance operations, largely offset a deliberate reduction in underwriting within the property-casualty reinsurance business.
Should investors sell immediately? Or is it worth buying Münchener Rück?
The Core Challenge: Shifting Pricing Dynamics
The pivotal development for the industry lies in the 1 January 2026 treaty renewal season. Munich Re reported that its renewed premium volume declined to €13.7 billion, a decrease of 7.8%. The company stated it consciously declined business that failed to meet its return requirements.
More significantly, after several years of rising rates, the group reported an inflation-adjusted price decline of 2.5% across its renewed portfolio. Prices for natural catastrophe coverage fell by approximately 6%. This disciplined underwriting signals robust risk management but also highlights increasing competitive pressures, forcing a renewed defense of pricing quality.
Strategic Outlook for 2026 and Beyond
Looking ahead, Munich Re has set a net profit target of €6.3 billion for 2026, roughly 5% above the 2025 result. The company also anticipates insurance revenue of €64 billion and an investment return exceeding 3.5%. Growth is expected to be driven primarily by the life and health segments and the direct insurance business with large industrial clients. Total reinsurance earnings are projected to rise from €5.2 billion to €5.4 billion.
Strategically, the “Ambition 2030” plan focuses on building more predictable earnings streams. The contribution from life/health, Global Specialty Insurance, and ERGO is targeted to increase from 50% to 60% by 2030. Concurrently, the group plans cost reductions of €600 million, which will involve cutting approximately 1,000 positions. Munich Re also intends to make significant investments in artificial intelligence.
The complete annual report for 2025 will be published on 18 March 2026. The first-quarter figures for 2026, due on 12 May 2026, will provide the first concrete indication of how the record profit and shareholder return framework align with the pricing pressures evident at the start of the new year.
Ad
Münchener Rück Stock: Buy or Sell?! New Münchener Rück Analysis from March 4 delivers the answer:
The latest Münchener Rück figures speak for themselves: Urgent action needed for Münchener Rück investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 4.
Münchener Rück: Buy or sell? Read more here...











